Aimovig Medication: What It Treats, How It Works, and What to Watch For

Aimovig medication is a prescription medicine used to help prevent migraine attacks in adults. It is not intended to stop a migraine that has already begun, and a clinician can help determine whether it is appropriate for an individual’s migraine pattern and medical history.

What is Aimovig medication?

Aimovig medication is a prescription preventive treatment for migraine in adults. Its active ingredient is erenumab-aooe, a type of medicine called a monoclonal antibody. It is designed to reduce the frequency of migraine attacks over time rather than provide rapid relief during an active attack.

Migraine is a neurological condition that can involve recurrent headache along with nausea, sensitivity to light or sound, and other symptoms. It may significantly affect work, school, family life and daily activities. People experiencing recurring migraine symptoms may benefit from a clinical assessment and an individualized prevention plan, including care for migraine.

Aimovig is administered under the skin using a prefilled autoinjector or syringe, according to the official prescribing information and a clinician’s instructions. Questions about the right dose, timing, injection technique, missed doses or storage should be directed to the prescribing clinician or pharmacist rather than managed independently.

What Aimovig is used for

Aimovig is approved for the preventive treatment of migraine in adults. Preventive treatment may be considered when migraine attacks are frequent, disabling, difficult to manage with acute medicines, or when acute medicines are not well tolerated. The goal is generally to lower the number of migraine days and lessen the overall burden of the condition.

It is not an acute pain-relief medicine. A person should not expect Aimovig to treat a migraine attack that is already underway. Clinicians may recommend a separate acute migraine treatment plan for attacks, while also considering preventive approaches.

The decision to use a preventive medicine depends on more than headache frequency. A clinician may review symptom patterns, aura, disability, previous treatments, other medical conditions, pregnancy considerations and the risk of medication-overuse headache. Keeping a headache diary can make this discussion more useful by recording migraine days, symptoms, triggers and medicines used.

How Aimovig works in migraine prevention

Calcitonin gene-related peptide, usually called CGRP, is a protein involved in pain signaling and blood vessel-related processes associated with migraine. CGRP levels and signaling can increase during migraine attacks. Aimovig works by binding to and blocking the CGRP receptor, which reduces activation of this pathway.

Because Aimovig is a monoclonal antibody, it differs from many traditional oral migraine-prevention medicines. It is not a standard painkiller and does not work by the same mechanism as anti-inflammatory medicines, triptans or many oral preventive treatments. Its effects are assessed over time, usually by tracking changes in migraine frequency and how migraine affects daily life.

Responses vary. Some people notice meaningful improvement, while others may not obtain sufficient benefit or may need a different preventive strategy. Regular follow-up helps the clinician assess benefit, side effects and whether the overall migraine plan remains suitable.

Side effects, warnings and precautions

The most commonly reported side effects of Aimovig include injection-site reactions, such as pain, redness or swelling, and constipation. Injection-site symptoms are often mild, but persistent, extensive or concerning skin reactions should be discussed with a healthcare professional.

Constipation can occasionally be severe and may require medical management. The risk may be greater for people with a history of constipation or those taking medicines that slow intestinal movement. A person should contact a clinician promptly if constipation is severe, persistent or accompanied by abdominal pain, vomiting or marked bloating.

Postmarketing reports have also included new or worsening high blood pressure and Raynaud’s phenomenon, a condition in which fingers or toes can become painful, numb or change color in response to cold or stress. People should discuss any history of high blood pressure or circulation symptoms with their clinician and report new symptoms during treatment.

Serious allergic reactions, including rash, swelling or breathing difficulty, have been reported and can occur after use. Aimovig should not be used by someone with a known serious hypersensitivity to erenumab-aooe or its ingredients. Emergency help is needed for signs of a severe allergic reaction, particularly trouble breathing or swelling of the face, mouth or throat.

Interactions and information to share with a clinician

As a monoclonal antibody, Aimovig is not expected to have many of the drug interactions seen with medicines processed through common liver enzyme systems. However, this does not mean a complete medication review is unnecessary. A clinician or pharmacist should know about all prescription medicines, over-the-counter products, vitamins, supplements and injectable treatments being used.

Before starting Aimovig, patients should share information about constipation or bowel problems, high blood pressure, heart or blood vessel conditions, Raynaud’s symptoms, latex sensitivity, allergies and any prior reaction to injectable medicines. The device components and packaging should be checked with a pharmacist if latex allergy is a concern.

People who are pregnant, planning pregnancy or breastfeeding should discuss potential benefits and uncertainties with their prescribing clinician. Available information may be limited, and decisions should be individualized. It is also important to tell the clinician about all migraine treatments, including acute medicines, so the complete plan can be reviewed safely.

• Bring a current medication and supplement list to appointments.
• Record migraine days and side effects between visits.
• Do not stop or start other prescribed medicines without professional advice.

Using Aimovig safely as part of a migraine plan

Aimovig should be used exactly as prescribed and in line with the approved product instructions. A clinician or pharmacist can demonstrate injection technique and explain how to store and handle the medicine. It should not be shared with another person, even if that person also has migraine.

Preventive medicine works best as one part of a broader migraine plan. This may include identifying personal triggers, maintaining regular sleep and meals, staying hydrated, managing stress where possible and using acute migraine medicines appropriately. Lifestyle measures do not replace medical treatment, but they may support symptom control for some people.

People should avoid changing the prescribed schedule or attempting to adjust doses on their own. If an injection is missed, damaged, frozen, left at an unsuitable temperature or otherwise uncertain, the prescriber or pharmacist can provide product-specific guidance. Follow-up appointments are an opportunity to decide whether the treatment is helping enough to continue.

When to seek medical care

Urgent medical assessment is important for a sudden, severe headache unlike previous headaches, often described as a thunderclap headache. Emergency care is also needed for headache with fainting, confusion, seizure, fever and neck stiffness, new weakness, numbness, speech difficulty, vision loss, severe head injury or other sudden neurological symptoms.

While using Aimovig, a person should seek prompt medical advice for severe or ongoing constipation, new or worsening high blood pressure symptoms, painful or discolored fingers or toes, or an unusual skin reaction. Signs of a serious allergic reaction, including difficulty breathing, wheezing, widespread hives, or swelling of the face, lips, tongue or throat, require emergency care.

It is also appropriate to arrange a non-urgent appointment when migraine changes substantially, attacks become more frequent, treatment is not helping, or acute medication is needed more often than recommended. Acibadem International’s multidisciplinary specialists and JCI-accredited hospitals can assess and treat migraine for international patients, with care plans tailored to the individual’s symptoms and health needs.

Frequently asked questions

Is Aimovig a painkiller?

No. Aimovig is a preventive migraine medicine, not a painkiller intended to stop an attack in progress. It is used regularly as prescribed to help reduce migraine frequency over time.

What is the active ingredient in Aimovig?

The active ingredient is erenumab-aooe. It is a monoclonal antibody that blocks the CGRP receptor, a signaling pathway involved in migraine.

What are the most common Aimovig side effects?

Commonly reported effects include injection-site reactions and constipation. A clinician should be contacted if constipation is severe or persistent, or if an injection-site reaction is extensive or concerning.

Can Aimovig raise blood pressure?

New or worsening high blood pressure has been reported after Aimovig use. People with high blood pressure or related risk factors should discuss monitoring and any concerning symptoms with their clinician.

Can Aimovig be used during pregnancy?

Anyone who is pregnant, planning pregnancy or breastfeeding should speak with a healthcare professional before using Aimovig. The clinician can consider the individual’s migraine burden, available safety information and treatment alternatives.

What should someone do if Aimovig does not seem to work?

They should continue only as directed and discuss their migraine diary and treatment response with the prescribing clinician. The clinician can assess whether enough time has passed to evaluate benefit and whether another approach may be more suitable.

References

• U.S. Food and Drug Administration
• European Medicines Agency
• American Headache Society
• National Institute of Neurological Disorders and Stroke

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.